AMEDEI, AMEDEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.676
EU - Europa 15.029
AS - Asia 11.245
SA - Sud America 1.445
Continente sconosciuto - Info sul continente non disponibili 636
AF - Africa 305
OC - Oceania 174
Totale 50.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.167
RU - Federazione Russa 4.254
IT - Italia 3.658
SG - Singapore 3.174
PL - Polonia 3.132
CN - Cina 2.900
HK - Hong Kong 1.683
BR - Brasile 1.122
VN - Vietnam 971
KR - Corea 950
IE - Irlanda 944
SE - Svezia 691
FI - Finlandia 536
FR - Francia 461
DE - Germania 405
IN - India 375
CA - Canada 308
GB - Regno Unito 297
BD - Bangladesh 278
ID - Indonesia 223
UA - Ucraina 183
AU - Australia 168
NL - Olanda 150
JO - Giordania 148
JP - Giappone 105
AR - Argentina 97
ES - Italia 80
EC - Ecuador 77
TR - Turchia 68
IQ - Iraq 65
MX - Messico 62
ZA - Sudafrica 52
CI - Costa d'Avorio 46
CH - Svizzera 45
CO - Colombia 45
NG - Nigeria 41
PK - Pakistan 37
EG - Egitto 34
AT - Austria 32
IR - Iran 29
VE - Venezuela 29
BE - Belgio 28
CL - Cile 28
JM - Giamaica 27
PH - Filippine 26
MA - Marocco 25
SA - Arabia Saudita 25
MY - Malesia 22
CZ - Repubblica Ceca 21
CR - Costa Rica 20
HN - Honduras 20
UZ - Uzbekistan 20
BJ - Benin 19
KE - Kenya 19
PY - Paraguay 19
BB - Barbados 17
LT - Lituania 17
PE - Perù 17
DZ - Algeria 16
LB - Libano 16
TN - Tunisia 16
IL - Israele 15
KZ - Kazakistan 15
RO - Romania 14
AE - Emirati Arabi Uniti 13
NP - Nepal 13
NI - Nicaragua 12
TH - Thailandia 12
EE - Estonia 11
SC - Seychelles 11
TW - Taiwan 11
KG - Kirghizistan 10
PT - Portogallo 9
AL - Albania 8
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
OM - Oman 8
RS - Serbia 8
SV - El Salvador 8
UY - Uruguay 8
GT - Guatemala 7
BG - Bulgaria 6
GR - Grecia 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
HR - Croazia 5
UG - Uganda 5
BY - Bielorussia 4
DK - Danimarca 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
BO - Bolivia 3
CG - Congo 3
ET - Etiopia 3
EU - Europa 3
HU - Ungheria 3
LV - Lettonia 3
MN - Mongolia 3
PR - Porto Rico 3
Totale 49.826
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.636
Warsaw 3.123
Ashburn 3.121
Singapore 2.373
Fairfield 1.297
Hong Kong 1.262
San Jose 992
Dublin 932
Seoul 926
Hefei 853
Chandler 701
Milan 588
Council Bluffs 582
Seattle 571
Woodbridge 565
Houston 527
Cambridge 520
Beijing 450
Florence 426
Wilmington 418
Los Angeles 354
Altamura 315
Lawrence 309
Rome 298
Helsinki 289
Ho Chi Minh City 282
Jacksonville 263
Lauterbourg 256
Ann Arbor 243
Buffalo 233
New York 224
Princeton 224
The Dalles 213
Hanoi 210
Chicago 192
Dallas 190
Moscow 184
Mumbai 177
Jakarta 162
Boston 161
Phoenix 153
Munich 148
Boardman 144
Melbourne 141
Kent 121
Shanghai 107
Medford 102
San Diego 100
São Paulo 97
Tokyo 92
Paris 91
Toronto 91
Lappeenranta 88
Dong Ket 86
Naples 70
Bologna 69
Turin 69
Atlanta 68
London 62
Clifton 58
Orem 58
Figino 54
Frankfurt am Main 54
Brooklyn 49
Guangzhou 49
Abidjan 46
Bengaluru 45
Da Nang 45
Montreal 45
Haiphong 41
Redondo Beach 41
Turku 41
San Francisco 40
Pune 39
Abuja 38
Palermo 37
Columbus 36
Falls Church 36
Denver 35
Bari 34
Miano 34
Salt Lake City 34
Guayaquil 33
Hillsboro 33
Brasília 30
Genoa 29
Baghdad 28
Rio de Janeiro 28
West Jordan 28
Chennai 27
Miami 26
Yubileyny 26
Vienna 25
Amman 24
Washington 24
Bern 22
Brussels 22
Catania 22
Johannesburg 22
Quito 22
Totale 32.001
Salva come PNG Salva come JPEG
Nome #
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 759
H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 421
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 414
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 375
Human 60 kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. 360
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 350
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. 338
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 318
Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration 312
Beneficial Effects of Micronutrient Supplementation in Restoring the Altered Microbiota and Gut–Retina Axis in Patients with Neovascular Age-Related Macular Degeneration—A Randomized Clinical Trial 311
Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. 311
The Neutrophil Activating Protein of Helicobacter pylori promotes T helper type 1 immune responses. 306
Molecular mimicry between Helicobacter pylori antigens and H/K-ATPase in human gastric autoimmunity. 305
Circulating Calprotectin (cCLP) in autoimmune diseases 299
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 295
Evaluation and comparison of short chain fatty acids composition in gut diseases 283
T cells in gastric cancer: friends or foes. 280
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 280
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 277
Healthy axis: Towards an integrated view of the gut-brain health 276
USE OF THE NEUTROPHIL ACTIVATING PROTEIN OF HELICOBACTER PYLORI (HP-NAP) AND/OR OF ITS PORTIONS AS ADJUVANTS FOR THE DEVELOPMENT OF T HELPER TYPE 1 (TH1) IMMUNE RESPONSES 276
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 275
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 270
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 268
T helper type-1 lymphocyte-drive inflammation in human atherosclerotic lesions. 264
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 260
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 254
I’ve gut a feeling: Microbiota impacting the conceptual and experimental perspectives of personalized medicine 254
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 252
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 247
Gastric cancer and the epoch of immunotherapy approaches 241
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 241
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. 240
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 240
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 238
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 238
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 238
Role of Gut Microbiota-Immunity Axis in Patients Undergoing Surgery for Colorectal Cancer: Focus on Short and Long-Term Outcomes 236
Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test 235
Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic 234
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 233
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 233
Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine 231
Preliminary Analysis of the Presence of Bacterial Azurin Coding Gene in CRC Patients and Correlation with the Microbiota Composition 230
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance 229
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 228
The lung microbiome: clinical and therapeutic implications 227
Effect of probiotics on oral candidiasis: A systematic review and meta-analysis 226
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 225
Thrombosis in vasculitis: from pathogenesis to treatment 222
Broad targeting of angiogenesis for cancer prevention and therapy 221
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 220
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine 216
The controversial role of Enterococcus faecalis in colorectal cancer 215
Effect of ancient wheat pasta on gut microbiota composition and bacteria-derived metabolites: A randomized controlled trial 213
A MULTI-DISEASE STATISTICAL ANALYSIS OF FREE FATTY ACID SIGNATURES ASSESSED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY 213
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A 213
Breast cancer: the first comparative evaluation of oncobiome composition between males and females 212
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 211
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 210
Circadian rhythms, gut microbiota, and diet: possible implications for health 209
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 208
Broad targeting of resistance to apoptosis in cancer 206
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 205
Designing a broad-spectrum integrative approach for cancer prevention and treatment 205
Exploring the food-gut axis in immunotherapy response of cancer patients 204
Vaginal lactobacilli and vaginal dysbiosis-associated bacteria differently affect cervical epithelial and immune homeostasis and anti-viral defenses 204
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 203
Characterization of H/K-ATPase T-cell epitopes in human autoimmune gastritis. 203
The interplay between the microbiome and the adaptive immune response in cancer development 202
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 202
Editorial of special issue “the interplay of microbiome and immune response in health and diseases” 201
Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients 201
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. 200
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 200
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 199
Tissue invasion and metastasis: Molecular, biological and clinical perspectives 199
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. 198
Hydrogen sulfide effects on the survival of lactobacilli with emphasis on the development of inflammatory bowel diseases 198
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 197
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. 196
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 195
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 194
Gut microbiota and artificial intelligence approaches: A scoping review 194
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 193
Bcl-2 Over-Expression in Human T-Cell Acute LymphocyticLeukemias is Consequent to mRNA Stabilization by Increased Binding to Zeta-Crystallin, a New Bcl-2 ARE-Binding Protein 193
Z-crystallin is a new stabilizing bcl-2 mRNA au-rich element binding protein overexpressed in the acute lymphocytic leukemia Jurkat T-CELL line 193
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: Focus on the cancer hallmark of tumor angiogenesis 188
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 187
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 187
The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers 187
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 186
Role of diet and gut microbiota on Colorectal cancer immunomodulation 186
Gut inflammatory diseases, infection, and nutrition 186
Cancer prevention and therapy through the modulation of the tumor microenvironment 186
A multi-targeted approach to suppress tumor-promoting inflammation 185
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 185
Facial Skin Microbiome: Aging-Related Changes and Exploratory Functional Associations with Host Genetic Factors, a Pilot Study 184
Effectiveness of a Khorasan Wheat–Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia 184
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 184
Totale 24.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.096 0 0 0 64 40 64 48 163 62 57 187 411
2022/20234.044 360 854 172 221 246 625 510 407 365 56 144 84
2023/20241.902 62 154 287 91 125 332 70 330 44 176 108 123
2024/202512.470 409 1.306 809 1.781 3.226 1.502 357 734 620 408 594 724
2025/202618.173 1.778 2.227 1.822 1.495 1.725 693 1.994 988 1.298 1.088 715 2.350
2026/20273.735 780 634 1.650 671 0 0 0 0 0 0 0 0
Totale 50.510